K D Friesgaard1,2, L Nikolajsen2, M Giebner3, C-H Rasmussen4, I S Riddervold1, H Kirkegaard5, E F Christensen1. 1. Research Department, Prehospital Emergency Medical Services, Central Denmark Region, Aarhus, Denmark. 2. Danish Pain Research Center and Department of Anesthesiology, Aarhus University Hospital, Aarhus, Denmark. 3. Falck Danmark A/S, Central Denmark Region, Kolding, Denmark. 4. Responce, Central Denmark Region, Horsens, Denmark. 5. Research Center for Emergency Medicine, Aarhus University Hospital, Aarhus, Denmark.
Abstract
BACKGROUND: Management of pain in the pre-hospital setting is often inadequate. In 2011, ambulance personnel were authorized to administer intravenous fentanyl in the Central Denmark Region. The aim of this study was to evaluate the efficacy and safety of intravenous fentanyl administered by ambulance personnel. METHODS: Pre-hospital medical charts from 2348 adults treated with intravenous fentanyl by ambulance personnel during a 6-month period were reviewed. The primary outcome was the change in pain intensity on a numeric rating scale (NRS) from before fentanyl treatment to hospital arrival. Secondary outcomes included the number of patients with reduction in pain intensity during transport (NRS ≥ 2), the number of patients with NRS > 3 at hospital arrival, and potential fentanyl-related side effects. RESULTS: Fentanyl reduced pain from before treatment (8, IQR 7-9) to hospital arrival (4, IQR 3-6) (NRS reduction: 3, IQR 2-5; P = 0.001), 79.3% of all patients had a reduction in > 2 on the NRS during transport, and 58.4% of patients experienced pain at hospital arrival (NRS > 3). Twenty-one patients (0.9%) had oxygen saturation < 90%. A decrease in Glasgow Coma Scale was seen in 31 patients (1.3%) and hypotension observed in 71 patients (3.0%). CONCLUSION: Intravenous fentanyl caused clinically meaningful pain reduction in most patients and was safe in the hands of ambulance personnel. Many patients had moderate to severe pain at hospital arrival. As the protocol allowed higher doses of fentanyl, feedback on effect and safety should be part of continuous education of ambulance personnel.
BACKGROUND: Management of pain in the pre-hospital setting is often inadequate. In 2011, ambulance personnel were authorized to administer intravenous fentanyl in the Central Denmark Region. The aim of this study was to evaluate the efficacy and safety of intravenous fentanyl administered by ambulance personnel. METHODS: Pre-hospital medical charts from 2348 adults treated with intravenous fentanyl by ambulance personnel during a 6-month period were reviewed. The primary outcome was the change in pain intensity on a numeric rating scale (NRS) from before fentanyl treatment to hospital arrival. Secondary outcomes included the number of patients with reduction in pain intensity during transport (NRS ≥ 2), the number of patients with NRS > 3 at hospital arrival, and potential fentanyl-related side effects. RESULTS:Fentanyl reduced pain from before treatment (8, IQR 7-9) to hospital arrival (4, IQR 3-6) (NRS reduction: 3, IQR 2-5; P = 0.001), 79.3% of all patients had a reduction in > 2 on the NRS during transport, and 58.4% of patients experienced pain at hospital arrival (NRS > 3). Twenty-one patients (0.9%) had oxygen saturation < 90%. A decrease in Glasgow Coma Scale was seen in 31 patients (1.3%) and hypotension observed in 71 patients (3.0%). CONCLUSION: Intravenous fentanyl caused clinically meaningful pain reduction in most patients and was safe in the hands of ambulance personnel. Many patients had moderate to severe pain at hospital arrival. As the protocol allowed higher doses of fentanyl, feedback on effect and safety should be part of continuous education of ambulance personnel.
Authors: D Häske; B W Böttiger; B Bouillon; M Fischer; Gernot Gaier; B Gliwitzky; M Helm; P Hilbert-Carius; B Hossfeld; B Schempf; A Wafaisade; M Bernhard Journal: Anaesthesist Date: 2020-02 Impact factor: 1.041
Authors: David Häske; Bernd W Böttiger; Bertil Bouillon; Matthias Fischer; Gernot Gaier; Bernhard Gliwitzky; Matthias Helm; Peter Hilbert-Carius; Björn Hossfeld; Christoph Meisner; Benjamin Schempf; Arasch Wafaisade; Michael Bernhard Journal: Dtsch Arztebl Int Date: 2017-11-17 Impact factor: 5.594
Authors: Kristian D Friesgaard; Erika F Christensen; Hans Kirkegaard; Mette D Bendtsen; Flemming B Jensen; Lone Nikolajsen Journal: Scand J Trauma Resusc Emerg Med Date: 2017-01-19 Impact factor: 2.953
Authors: Niklas Lenssen; Andreas Krockauer; Stefan K Beckers; Rolf Rossaint; Frederik Hirsch; Jörg C Brokmann; Sebastian Bergrath Journal: Sci Rep Date: 2017-05-08 Impact factor: 4.379
Authors: Christopher Rugg; Simon Woyke; Wolfgang Voelckel; Peter Paal; Mathias Ströhle Journal: Scand J Trauma Resusc Emerg Med Date: 2021-02-01 Impact factor: 2.953
Authors: Patrick D Dißmann; Maxime Maignan; Paul D Cloves; Blanca Gutierrez Parres; Sara Dickerson; Alice Eberhardt Journal: Pain Ther Date: 2018-06-02